OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
February 15, 2021
Nanoform and Herantis have signed a biologics proof of concept agreement for formulation proof of concept projects aimed at improving nasal drug delivery to the brain.
February 03, 2021
Rapid growth in biologics and increasing complexity of new compounds are some of the factors driving development of innovative delivery solutions.
February 02, 2021
Outsourcing partners can provide a multitude of advantages in the development of drug delivery solutions, including those designed for targeted patient populations.
January 27, 2021
The project is aimed at discovering novel transport mechanisms in the human intestinal tract that could be used for oral delivery of diverse therapeutic modalities.
January 20, 2021
Leveraging real-time MRI guidance for intracranial gene therapy administration potentially improves efficacy and outcomes.
December 10, 2020
Evonik offers lipid nanoparticles for gene-based drug development and manufacturing.
December 03, 2020
Study results indicate that fatty alcohols may plausibly enhance the skin permeation of clotrimazole.
November 30, 2020
Behzad Mahdavi, PhD, will join a team of experts in the company’s Science and Technology Group to fast-track the adoption of new development and drug delivery technologies and manufacturing processes and techniques.
November 03, 2020
Amorphous solid dispersions are a useful tool in overcoming solubility issues, but they have not yet reached full potential in commercial success.
October 07, 2020
Schott and Credence MedSystems have formed a strategic collaboration to make syringe injections safer.
October 06, 2020
Eudratec Fasteric is an oral drug delivery technology that offers enteric protection after rapid, homogeneous release for targeting the upper small intestine.
September 22, 2020
The companies will work together to produce a wearable device that can subcutaneously deliver ketamine therapy as a non-opioid pain treatment.
September 03, 2020
A device manufacturing process must be carefully designed in the early stages of development to ensure success in commercial manufacturing.
August 03, 2020
This study suggests that using a simple centrifugal method can produce a natural polymer-blend molecule that can successfully be used as an oral delivery mechanism for poorly soluble drugs.
July 30, 2020
Pharmapack Europe 2021 has been rescheduled after a careful review by the event organizers with key stakeholders.
July 07, 2020
The new site will offer initial design and development, low-volume manufacturing, and scalable high-quality production of wearable drug delivery devices.
July 02, 2020
Controlled-release formulations offer numerous advantages for developers and patients, and this market is expected to continue to experience growth in the near future.
June 24, 2020
Inovio received a $71-million contract from the US Department of Defense to scale up manufacture of its Cellectra smart device to deliver its DNA vaccine.
June 04, 2020
The investment will give the company the opportunity to accelerate the development of proprietary boron-10 target drugs while it develops its neutron beam accelerator technology for Boron Neutron Capture Therapy.
June 02, 2020
The correct mix of excipients is crucial to the success of fast dissolving/orally disintegrating dosage forms.